investigational

Related by string. Investigational * * investigational compounds . Investigational Device Exemption IDE . Investigational Device Exemption . investigational compound . Investigational NDAs . investigational drug . investigational oral . investigational mTOR inhibitor . IND Investigational New . includes investigational compounds . Investigational Drug . investigational therapies *

Related by context. Frequent words. (Click for all words.) 69 investigational drug 67 Investigational 67 investigational compound 66 clinical trial 64 Phase III clinical 63 clinical trials 63 Phase III clinical trials 63 investigational oral 62 Investigational Device Exemption IDE 62 Phase IIa trial 61 orally administered 60 oral formulation 60 Perifosine 60 Marqibo 59 Phase 2b study 59 antisense drug 59 Phase IIa 59 Orphan Drug 58 pivotal Phase III 58 Phase IIb 58 Phase 2b clinical 58 TREANDA 58 preclinical 58 Phase 2a trial 58 perifosine 58 Phase Ib 58 NGX# 57 Phase III trials 57 Phase 2a clinical 57 INDs 57 satraplatin 57 Biologics License Application BLA 57 Phase IIb trial 57 HDAC inhibitor 56 clofarabine 56 orphan drug 56 humanized monoclonal antibody 56 RG# [001] 56 preclinical studies 56 Phase 2b trial 56 tablet formulation 56 Phase IIa clinical 56 Clolar 56 New Drug IND 56 ZYBRESTAT 56 AP# [003] 56 Iluvien 55 dose escalation trial 55 MGCD# [001] 55 Phase III 55 Ceftobiprole 55 Marketing Authorization Application 55 Biologics License Application 55 New Drug Application 55 Bronchitol 55 Phase IIb clinical 55 recombinant human 55 BiTE antibody 55 Picoplatin 55 pharmacokinetic 55 Satraplatin 55 efficacy 55 Orphan Drug designation 55 carfilzomib 55 CRx 55 immunosuppressant 55 Cimzia ® 55 pivotal Phase 55 immunotherapeutic 55 Amitiza 54 CYT# 54 T DM1 54 Alpharadin 54 prodrug 54 lubiprostone 54 Drug Administration FDA 54 intravenous formulation 54 NKTR 54 JANUVIA 54 ISENTRESS 54 sBLA 54 Peramivir 54 phase IIb 54 Actemra 54 disease modifying 54 Phase 2a 54 ADVEXIN 54 Homspera 54 Orphan Drug Designation 54 RDEA# 54 dose escalation study 54 cancer immunotherapy 54 injectable 54 APF# 54 IND enabling 53 Prochymal 53 Vasovist 53 linaclotide 53 transdermal patch 53 pralatrexate 53 Rifaximin

Back to home page